ARCHIVES

Investigation finds no evidence FDA’s Crawford had affair with subordinate.

This article is from The Cancer Letter archive.

Vol. 31 No. 23 | June 10, 2005

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

Strict System For Protection Of Human Subjects Ordered In Wake Of NIH Investigation

August 9, 1991

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

Henry Brem Named Director Of Neurology At Johns Hopkins.

July 28, 2000